Home Publications Research Grants Inventions & Patents Awards Additional Research Activities Faculties & Institutions Research Areas

No need for constant help: human IgG2 antibodies have an autonomous agonistic activity for immunotherapy of cancer.

Lux A, Nimmerjahn F (2015)

---

Publication Status: Published

Publication Type: Journal article

Publication year: 2015

Journal

Book Volume: 27

Pages Range: 10-1

Journal Issue: 1

DOI: 10.1016/j.ccell.2014.12.010

Abstract

Agonistic antibodies specific for members of the tumor necrosis factor receptor protein family hold great promise for immunotherapy of cancer. In this issue of Cancer Cell, White and colleagues provide evidence that the human IgG2 subclass may represent a superior backbone for the use of these antibodies in human therapy.

Authors with CRIS profile

How to cite

APA:

Lux, A., & Nimmerjahn, F. (2015). No need for constant help: human IgG2 antibodies have an autonomous agonistic activity for immunotherapy of cancer. Cancer cell, 27(1), 10-1. https://doi.org/10.1016/j.ccell.2014.12.010

MLA:

Lux, Anja, and Falk Nimmerjahn. "No need for constant help: human IgG2 antibodies have an autonomous agonistic activity for immunotherapy of cancer." Cancer cell 27.1 (2015): 10-1.

BibTeX: Download